Myasthenia gravis (MG) is an autoimmune neuromuscular disorder characterized by circulating autoantibodies against functionally important components of the postsynaptic membrane, including acetylcholine receptor (AChR) and muscle-specific tyrosine kinase (MuSK). This evidence concerns the gene MUSK and myasthenia gravis.